Tag Archives: Hematology/Oncology

Catastrophic Antiphospholipid Syndrome, +/- Heparin induced thrombocytopenia & thrombosis, +/- SLE 8/1/2018

Wendy presented a fascinating (and confusing!) case of a patient with history of APS and DVT/PE on chronic warfarin presenting with painful, non-blanching, palpable purpuric rash on the left thigh and lower abdomen found to have thrombocytopenia,  and proteinuria. Skin biopsy revealed small vessel microthrombi. Work up positive SRA, positive ANA, positive DsDNA, low complements… Base on this presentation, the patient possibly has catastrophic antiphospholipid syndrome, with heparin induced thrombocytopenia, and newly diagnosed SLE!

CAPS1CAPS2CAPS3.JPG

Cholangiocarcinoma – 7/11/18

Eric presented the case of an elderly woman with no known medical history presenting with subacute onset of painless jaundice and liver failure, found to have perihilar cholangiocarcinoma.


Clinical Pearls:

  • Cholangiocarcinomas are the second most common primary malignancy of the liver after HCC.
  • Perihilar disease is most common.  Can also present with intrahepatic or distal duct involvement.
  • Risk factors include Primary Sclerosing Cholangitis, parasites, and biliary cysts.
  • Metastases occur early in the disease course with the liver being the most common site.
  • Treatment
    • Distal cholangiocarcinoma has the highest resectability.
    • Surgery is the only cure but only a minority of patients present early enough

Capture

Cholangiocarcinoma:

  • Second most common primary malignancy of liver after HCC
  • Can be intrahepatic, perihilar (most common), or distal
  • Risk factors include:
    • PSC
    • Parasitic infections (liver flukes: clonorchis and Opisthorchis)
    • Biliary atresia
    • Biliary cysts
    • Cholelithiasis, cholecystitis, and hepatolithiasis
  • Mets occur early in disease course except for distal disease
    • Perihilar disease: liver is the most common site of met
    • Intrahepatic: peritoneum, lungs, pleura
    • Distal cholangiocarcinoma: liver, lungs, peritoneum
  • Treatment:
    • Distal disease has the highest resectability
    • Surgery is the only cure but only a minority of patients present early enough
    • Liver transplant in an option for those with
      • perihilar disease
      • < 3 cm tumor size
      • No extrahepatic spread
      • No percutaneous biopsy (increases risk of hematogenous spread)

 

B12 deficiency induced hemolytic anemia – 6/27/18

Ernest presented an interesting case of a middle aged man with h/o CVA presenting with symptomatic megaloblastic anemia, found to have vitamin B12 deficiency induced thrombotic microangiopathy!


Clinical Pearls:

  • A “pseudo” TMA can develop in patients with severe vitamin B12 deficiency via red cell destruction in the bone marrow, leading to high LDH but modest rise in total bilirubin.
  • B12 related hemolysis is similar to TTP so the latter must be ruled out!
  • Treatment involves aggressive vitamin B12 replacement and is not responsive to plasmapharesis.

Differential for megaloblastic (MCV >120) anemia:

  • Vitamin B12 deficiency (elevation of both MMA and homocysteine)
  • Folate deficiency (elevation of homocysteine alone)
  • Drug induced (methotrexate, hydroxyurea, zidovudine, azathioprine, 5-FU, acyclovir, capecitabine)
  • Copper deficiency

When schistocytes are on the smear –> non-immune hemolysis.

Primary TMA syndromes:

  • TTP
    • Low levels of ADAMTS13
    • Renal failure, neurologic changes, fever, schistocytes, thrombocytopenia
      • Classic pentad only seen in 1/3 of patients
      • Triad of elevated LDH, schistos, and thrombocytopenia? –> check ADAMTS13
  • Shiga toxin mediated HUS
    • Shigella and certain serotypes of E Coli such as O157:H7 and O104:H4.
    • Classically with renal dysfunction and HTN as predominant findings
    • Bloody diarrhea
    • More common in children
  • Complement mediated
    • Hereditary deficiency of regulatory proteins in the alternative complement pathway
  • Drug mediated
    • Quinine, quetiapine, immunosuppressants, chemotherapy, calcineurin inhibitors
  • Metabolism mediated
    • Cobalamin C deficiency (inborn error of metabolism)
      • Mutations in the MMACHC gene (methylmalonic aciduria and homocystinuria type C)
  • Coagulation mediated
    • Hereditary deficiency of proteins in the coag pathway

Systemic disorder associated with MAHA and thrombocytopenia:

  • Pregnancy complications (HELLP)
  • Severe HTN
  • Systemic infections (bacterial endocarditis, HIV, CMV, RMSF)
  • Malignancies (with or without DIC)
  • Autoimmune diseases: SLE, systemic scleroderma, APLS.
  • DIC
  • Severe vitamin B12 deficiency

Final note on pernicious anemia:

  • Most common in Nothern Europeans
  • Check in people with vitamin B12 deficiency and no other identifiable cause
  • Intrinsic factor antibodies are the test of choice
    • Low sensitivity but high specificity
    • High sensitivity but low specificity (seen in other autoimmune disease as well as healthy individuals without autoimmune disease)
  • What about Schilling test?
    • Not available anymore!

References:

Acharya et al. Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature. J Hematol Oncol. 2008.